Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study. - Sehouli, J; Reinthaller, A; Marth, C; Reimer, D; Reimer, T; Stummvoll, W; Angleitner-Boubenizek, L; Brandt, B; Chekerov, R (British Journal of Cancer, 2014)